Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Jan-24 5:04 PM View:  | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-24 | Grant | 1,500,000 | -- | -- | 65% 2.32M to 3.82M | |
| 09-Aug-23 6:57 PM View: | Xeris Biopharma Holdings, I... (XERS) | 09-Aug-23 | Market Purchase | 10,000 | $2.38 | $23,794.00 | < 1% 2.31M to 2.32M | 3% |
| 01-Feb-23 4:13 PM View: | Xeris Biopharma Holdings, I... (XERS) | 31-Jan-23 | Grant | 750,000 | -- | -- | 48% 1.56M to 2.31M | |
| 14-Dec-22 4:11 PM View: | Xeris Biopharma Holdings, I... (XERS) | 13-Dec-22 | Private Purchase | 20,000 | $1.45 | $29,000.00 | 1% 1.54M to 1.56M | |
| 13-May-22 4:19 PM View: | Xeris Biopharma Holdings, I... (XERS) | 12-May-22 | Private Purchase | 100,000 | $1.40 | $140,380.00 | 7% 1.44M to 1.54M | |
| 05-Jan-22 6:16 PM View: | Xeris Biopharma Holdings, I... (XERS) | 03-Jan-22 | Grant | 600,000 | -- | -- | 71% 841.49K to 1.44M | |
| 16-Nov-21 4:25 PM View: | Xeris Biopharma Holdings, I... (XERS) | 15-Nov-21 | Market Purchase | 20,000 | $2.28 | $45,664.00 | 2% 821.49K to 841.49K | 9% |
| 12-Nov-21 5:09 PM View: | Xeris Biopharma Holdings, I... (XERS) | 11-Nov-21 | Market Purchase | 200,000 | $2.08 | $415,760.00 | 32% 621.49K to 821.49K | < 1% |
| 05-Oct-21 5:36 PM View: | Xeris Pharmaceuticals Inc (XERS) | 05-Oct-21 | Disposition | 608,064 | -- | -- | (98%) 621.49K to 13.43K | |
| 05-Oct-21 5:36 PM View: | Xeris Pharmaceuticals Inc (XERS) | 05-Oct-21 | Disposition | 13,430 | -- | -- | (100%) 13.43K to 0 | |
| 05-Oct-21 7:49 PM View: | Xeris Biopharma Holdings, I... (XERS) | 05-Oct-21 | Grant | 608,064 | -- | -- | 100% 0 to 608.06K | |
| 05-Oct-21 7:49 PM View: | Xeris Biopharma Holdings, I... (XERS) | 05-Oct-21 | Grant | 13,430 | -- | -- | 2% 608.06K to 621.49K | |
| 01-Feb-21 4:22 PM View: | Xeris Pharmaceuticals Inc (XERS) | 29-Jan-21 | Grant | 225,000 | -- | -- | 53% 424.56K to 649.56K | |
| 10-Dec-20 4:52 PM View: | Xeris Pharmaceuticals Inc (XERS) | 09-Dec-20 | Market Purchase | 10,000 | $4.06 | $40,551.00 | 2% 414.56K to 424.56K | 25% |
| 11-May-20 5:06 PM View: | Xeris Pharmaceuticals Inc (XERS) | 08-May-20 | Market Purchase | 33,000 | $3.00 | $99,000.00 | 9% 381.56K to 414.56K | 69% |
| 18-Feb-20 5:02 PM View: | Xeris Pharmaceuticals Inc (XERS) | 14-Feb-20 | Market Purchase | 20,000 | $4.15 | $83,000.00 | 11% 176.56K to 196.56K | 22% |
| 02-Mar-20 4:52 PM View: | Xeris Pharmaceuticals Inc (XERS) | 31-Jan-20 | Grant | 185,000 | -- | -- | 94% 196.56K to 381.56K | |
| 04-Feb-20 5:00 PM View: | Xeris Pharmaceuticals Inc (XERS) | 31-Jan-20 | Payment of Exercise | 9,801 | $6.37 | $62,432.40 | (5%) 186.37K to 176.56K | 20% |
| 27-Nov-19 4:43 PM View: | Xeris Pharmaceuticals Inc (XERS) | 25-Nov-19 | Market Purchase | 17,935 | $8.55 | $153,283.00 | 11% 168.43K to 186.37K | (41%) |
| 29-May-19 4:24 PM View: | Iterum Therapeutics Plc (ITRM) | 24-May-19 | Option Exercise | 6,154 | -- | -- | 24% 25.24K to 31.39K | |
| 12-Mar-19 7:15 PM View: | Xeris Pharmaceuticals Inc (XERS) | 11-Mar-19 | Market Purchase | 30,000 | $9.12 | $273,585.00 | 22% 138.43K to 168.43K | (44%) |
| 01-Feb-19 4:42 PM View: | Xeris Pharmaceuticals Inc (XERS) | 31-Jan-19 | Grant | 125,000 | -- | -- | 931% 13.43K to 138.43K | |
| 27-Aug-18 5:15 PM View: | Iterum Therapeutics Plc (ITRM) | 23-Aug-18 | Purchase | 500 | $10.44 | $5,218.70 | 2% 24.74K to 25.24K | |
| 27-Jun-18 8:38 PM View: | Xeris Pharmaceuticals Inc (XERS) | 25-Jun-18 | Conversion | 13,430 | -- | -- | 100% 0 to 13.43K | |
| 12-Jun-18 4:29 PM View: | PDL BioPharma Inc. (PDLI) | 08-Jun-18 | Grant | 54,348 | $2.76 | $150,000.00 | 34% 160.22K to 214.56K | (4%) |
| 30-May-18 10:00 PM View: | Iterum Therapeutics Plc (ITRM) | 30-May-18 | Conversion | 21,554 | -- | -- | 677% 3.18K to 24.74K | |
| 13-Feb-18 4:54 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 14,930 | $18.00 | $268,740.00 | (100%) 14.93K to 0 | |
| 12-Jun-17 8:19 PM View: | PDL BioPharma Inc. (PDLI) | 09-Jun-17 | Grant | 60,729 | $2.47 | $150,001.00 | 61% 99.49K to 160.22K | 7% |
| 05-Jun-17 9:59 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 01-Jun-17 | Grant | 5,130 | -- | -- | 52% 9.8K to 14.93K | |
| 03-Aug-16 6:20 PM View: | Sucampo Pharmaceuticals, Inc. (SCMP) | 01-Aug-16 | Grant | 14,700 | -- | -- | 100% 0 to 14.7K | |
| 03-Jun-16 6:26 PM View: | PDL BioPharma Inc. (PDLI) | 02-Jun-16 | Grant | 71,023 | $3.52 | $250,001.00 | 250% 28.46K to 99.49K | (25%) |
| 08-Sep-15 5:19 PM View: | PDL BioPharma Inc. (PDLI) | 08-Sep-15 | Grant | 28,463 | $5.27 | $150,000.00 | 100% 0 to 28.46K | (46%) |
| 04-May-15 6:43 PM View: | Lumos Pharma, Inc. (LUMO) | 30-Apr-15 | Grant | 1,962 | -- | -- | 33% 5.94K to 7.91K | |
| 18-Nov-14 6:29 PM View: | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 46,136 | -- | -- | (100%) 46.14K to 0 | |
| 13-Jun-14 1:53 PM View: | Durata Therapeutics, Inc. (DRTX) | 12-Jun-14 | Market Purchase | 3,000 | $15.23 | $45,690.00 | 7% 43.14K to 46.14K | 58% |
| 05-May-14 4:21 PM View: | Lumos Pharma, Inc. (LUMO) | 01-May-14 | Grant | 2,944 | -- | -- | 98% 3.0K to 5.94K | |
| 06-Jan-14 7:45 PM View: | Lumos Pharma, Inc. (LUMO) | 02-Jan-14 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 20-May-13 1:36 PM View: | Durata Therapeutics, Inc. (DRTX) | 20-May-13 | Market Purchase | 3,000 | $7.09 | $21,267.00 | 7% 40.14K to 43.14K | 239% |
| 16-Aug-12 3:03 PM View: | Durata Therapeutics, Inc. (DRTX) | 14-Aug-12 | Market Purchase | 5,000 | $8.65 | $43,250.00 | 25% 19.64K to 24.64K | 178% |
| 26-Jul-12 5:54 PM View: | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion | 19,636 | -- | -- | 100% 0 to 19.64K | |
| 14-Feb-13 5:59 PM View: | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase | 15,500 | $9.00 | $139,500.00 | 24% 64.27K to 79.77K |